Related Experiment Videos
Myotonic muscular dystrophy associated with ritodrine tocolysis
American Journal of Obstetrics and Gynecology
|January 1, 1985
Summary
Ritodrine hydrochloride, used to treat premature labor, unmasked previously unsuspected myotonic dystrophy in a patient. This case highlights the importance of considering genetic conditions when adverse drug reactions occur.
Area of Science:
- Neurology
- Obstetrics
- Pharmacology
Background:
- Premature labor management often involves beta-mimetic agents.
- Myotonic dystrophy is a genetic neuromuscular disorder.
- Undiagnosed genetic conditions can complicate pregnancy management.
Observation:
- A patient receiving ritodrine hydrochloride for preterm labor developed symptoms suggestive of myotonic dystrophy.
- Neurological assessment revealed previously unknown myotonic dystrophy in the patient and her family members.
- Discontinuing ritodrine improved myotonia but exacerbated labor; magnesium sulfate was ineffective.
Findings:
- Ritodrine hydrochloride administration unmasked latent myotonic dystrophy.
- Congenital myotonia was diagnosed in the neonate.
- Long-term management with bed rest, phenytoin, and isoxsuprine hydrochloride led to successful term delivery.
Implications:
- Beta-mimetic drugs may unmask underlying myotonic dystrophy.
- Genetic screening may be considered in pregnant patients with unexplained symptoms during tocolytic therapy.
- Further research is needed to elucidate the mechanism of ritodrine-induced myotonia unmasking.